88 related articles for article (PubMed ID: 11370932)
1. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey.
Deubner DC; Goodman M; Iannuzzi J
Appl Occup Environ Hyg; 2001 May; 16(5):521-6. PubMed ID: 11370932
[TBL] [Abstract][Full Text] [Related]
2. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
Stange AW; Furman FJ; Hilmas DE
Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
[TBL] [Abstract][Full Text] [Related]
3. Beryllium health effects in the era of the beryllium lymphocyte proliferation test.
Maier LA
Appl Occup Environ Hyg; 2001 May; 16(5):514-20. PubMed ID: 11370931
[TBL] [Abstract][Full Text] [Related]
4. [Beryllium--underestimated occupational health hazard in Poland].
Dudek W; Walusiak J; Wittczak T
Med Pr; 2001; 52(6):471-8. PubMed ID: 11928678
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity.
Milovanova TN
Cytometry B Clin Cytom; 2007 Jul; 72(4):265-75. PubMed ID: 17328032
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
Cher DJ; Deubner DC; Kelsh MA; Chapman PS; Ray RM
Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408
[TBL] [Abstract][Full Text] [Related]
7. Introduction to beryllium: uses, regulatory history, and disease.
Kolanz ME
Appl Occup Environ Hyg; 2001 May; 16(5):559-67. PubMed ID: 11370935
[TBL] [Abstract][Full Text] [Related]
8. Chronic beryllium disease: a hypersensitivity disorder.
Rossman MD
Appl Occup Environ Hyg; 2001 May; 16(5):615-8. PubMed ID: 11370939
[TBL] [Abstract][Full Text] [Related]
9. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
Kreiss K; Wasserman S; Mroz MM; Newman LS
J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
[TBL] [Abstract][Full Text] [Related]
10. Beryllium hypersensitivity and chronic beryllium lung disease.
Santo Tomas LH
Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
[TBL] [Abstract][Full Text] [Related]
11. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
[TBL] [Abstract][Full Text] [Related]
12. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
[TBL] [Abstract][Full Text] [Related]
13. The BeLPT: algorithms and implications.
Middleton DC; Lewin MD; Kowalski PJ; Cox SS; Kleinbaum D
Am J Ind Med; 2006 Jan; 49(1):36-44. PubMed ID: 16362939
[TBL] [Abstract][Full Text] [Related]
14. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
Kent MS; Robins TG; Madl AK
Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
[TBL] [Abstract][Full Text] [Related]
15. Optimizing BeLPT criteria for beryllium sensitization.
Middleton DC; Fink J; Kowalski PJ; Lewin MD; Sinks T
Am J Ind Med; 2008 Mar; 51(3):166-72. PubMed ID: 18181198
[TBL] [Abstract][Full Text] [Related]
16. Recent chronic beryllium disease in residents surrounding a beryllium facility.
Maier LA; Martyny JW; Liang J; Rossman MD
Am J Respir Crit Care Med; 2008 May; 177(9):1012-7. PubMed ID: 18244954
[TBL] [Abstract][Full Text] [Related]
17. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.
Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF;
Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119
[TBL] [Abstract][Full Text] [Related]
18. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric test for beryllium sensitivity.
Milovanova TN; Popma SH; Cherian S; Moore JS; Rossman MD
Cytometry B Clin Cytom; 2004 Jul; 60(1):23-30. PubMed ID: 15221866
[TBL] [Abstract][Full Text] [Related]
20. Identifying an apppropriate occupational exposure limit (OEL) for beryllium: data gaps and current research initiatives.
Paustenbach DJ; Madl AK; Greene JF
Appl Occup Environ Hyg; 2001 May; 16(5):527-38. PubMed ID: 11370933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
